Evidence map›Paper›PMID 31558457›Full record

SynthesisBMJ open2019

Endorsement of reporting guidelines and study registration by endocrine and internal medicine journals: meta-epidemiological study.

Jorge Alberto Zuñiga-Hernandez, Edgar Gerardo Dorsey-Treviño, Jose Gerardo González-González, Juan P Brito, Victor M Montori, Rene Rodriguez-Gutierrez

Abstract readMeta-Analysis
In one paragraph

Synthesis in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jorge Alberto Zuñiga-Hernandez *Endocrinology Division, Department of Internal Medicine, University Hospital 'Dr. José E. González', Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.ORCID 0000-0002-2038-609X
Edgar Gerardo Dorsey-Treviño *Endocrinology Division, Department of Internal Medicine, University Hospital 'Dr. José E. González', Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.ORCID 0000-0001-6082-0631
Jose Gerardo González-GonzálezEndocrinology Division, Department of Internal Medicine, University Hospital 'Dr. José E. González', Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Juan P BritoKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
Victor M MontoriKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
Rene Rodriguez-GutierrezEndocrinology Division, Department of Internal Medicine, University Hospital 'Dr. José E. González', Universidad Autonoma de Nuevo Leon, Monterrey, Mexico rodriguezgutierrez.rene@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo improve the trustworthiness of evidence, studies should be prospectively registered and research reports should adhere to existing standards. We aimed to systematically assess the degree to which endocrinology and internal medicine journals endorse study registration and reporting standards for randomised controlled trials (RCTs), systematic reviews (SRs) and observational studies (ObS). Additionally, we evaluated characteristics that predict endorsement of reporting or registration mechanism by these journals.

designMeta-epidemiological study.

settingJournals included in the 'Endocrinology and Metabolism' and 'General and Internal Medicine' 2017 Journal Citation Reports.

participantsJournals with an impact factor of ≥1.0, focused on clinical medicine, and those who publish RCTs, SRs and ObS were included. PRIMARY OUTCOMES: Requirement of adherence to reporting guideline and study registration as determined from the journals' author instructions.

resultsOf the 170 (82 endocrinology and 88 internal medicine) eligible journals, endorsing of reporting standards was the highest for RCTs, with 35 (43%) of endocrine journals and 55 (63%) of internal medicine journals followed by SRs, with 21 (26%) and 48 (55%), respectively, and lastly, by ObS with 41 (50%) of endocrine journals and 21 (24%) of internal medicine journals. In 78 (46%) journals RCTs were required to be registered and published in adherence to the Consolidated Standards of Reporting Trials statement. Only 11 (6%) journals required registration of SRs. Internal medicine journals were more likely to endorse reporting guidelines than endocrine journals except for Strengthening the Reporting of Observational Studies in Epidemiology. No other journal characteristic proved to be an independent predictor of reporting standard endorsement for RCTs besides trial registration.

conclusionOur results highlight that study registration requirement and reporting guideline endorsement are suboptimal in internal medicine and endocrine journals. This malpractice may be further enhanced since endorsement does not imply enforcement, impairing the practice of evidence-based medicine.

Indexed as

Editorial PoliciesEndocrinologyEvidence-Based MedicineGuideline AdherenceInternal MedicinePeriodicals as TopicResearch ReportEpidemiologic StudiesHumansObservational Studies as TopicPublishingRecordsendocrinologyendorsementinternal medicineregistrationreporting guidelines

Identifiers

PMID31558457
PMCPMC6773296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.